Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Celsion Corp (CLSN)

1.85   -0.19 (-9.31%) 03-05 09:01
Open: 2.01 Pre. Close: 2.04
High: 2.01 Low: 1.62
Volume: 10,553,128 Market Cap: 135M
Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.012 - 2.029 2.029 - 2.04
Low: 1.592 - 1.607 1.607 - 1.617
Close: 1.828 - 1.854 1.854 - 1.872

Technical analysis

as of: 2021-03-05 8:44:16 AM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.10     One year: 4.06
Support: Support1: 1.32    Support2: 1.10
Resistance: Resistance1: 2.65    Resistance2: 3.48
Pivot: 2.19
Moving Average: MA(5): 2.05     MA(20): 2.12
MA(100): 1.03     MA(250): 1.38
MACD: MACD(12,26): 0.16     Signal(9): 0.24
Stochastic oscillator: %K(14,3): 18.14     %D(3): 21.73
RSI: RSI(14): 48.69
52-week: High: 6.50  Low: 0.43  Change(%): 59.5
Average Vol(K): 3-Month: 1962123  10-Days: 4317464

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CLSN has closed above bottom band by 14.2%. Bollinger Bands are 88.4% wider than normal. The large width of the bands suggest high volatility as compared to CLSN's normal range. The bands have been in this wide range for 30 bars. This is a sign that the current trend might continue.

Headline News

Thu, 25 Feb 2021
Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores - GlobeNewswire

Mon, 22 Feb 2021
CLSN Stock: Why Biotech Celsion Is Soaring Today - Nasdaq

Mon, 22 Feb 2021
Mid-day market update: Nasdaq tumbles 250 points; Celsion (CLSN Stock) shares spike higher - FXStreet

Mon, 22 Feb 2021
Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer - GlobeNewswire

Fri, 12 Feb 2021
Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech? - PRNewswire

Fri, 12 Feb 2021
Celsion Corporation Announces Formation of Vaccine Advisory Board - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37
Shares Float (M) 37
% Held by Insiders 1.25
% Held by Institutions 17.99
Shares Short (K) 1,420
Shares Short P. Month (K) 1,220

Stock Financials

EPS -0.747
EPS Est This Year -3.500
EPS Est Next Year -1.170
Book Value (p.s.) 0.520
Profit Margin
Operating Margin -3688.04
Return on Assets (ttm) -29.6
Return on Equity (ttm) -126.5
Qtrly Rev. Growth
Gross Profit (p.s.) -0.336
Sales Per Share 0.013
EBITDA (p.s.) -0.472
Qtrly Earnings Growth
Operating Cash Flow (M) -18
Levered Free Cash Flow (M) -12

Stock Valuations

PE Ratio -2.48
PEG Ratio
Price to Book value 3.56
Price to Sales 138.45
Price to Cash Flow -3.96

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.